Advertisement
Guest Editorial

AACR conference examines how societal framework of racism drives cancer disparities

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
BYLINEDOWNLOAD PDFTABLE OF CONTENTS

The global coronavirus pandemic has torn the veil that dimmed the nation’s awareness of the breadth and depth of health disparities, including cancer health disparities.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Advertisement
Advertisement
Byline
Steven R. Patierno, PhD
Deputy director, Duke Cancer Institute; Professor of medicine, pharmacology and cancer biology, professor of family medicine and community health, Duke University School Medicine; Conference co-chair, AACR Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved
Table of Contents
Advertisement
Advertisement

YOU MAY BE INTERESTED IN

Genetic counseling can improve genetic screening and accelerate clinical trial success

In an effort to target the right patients, genetic screening is becoming more common in clinical trials. But incorporating it can be complex and add a significant burden for both patients and clinical trial sites. Genetic counseling can streamline that process and help drug and gene therapy developers expedite the recruitment of genetically-eligible participants for their trials and use genetic testing results to accelerate the speed and success of clinical trials.
By Ashley Cannon
Advertisement
Advertisement